comparemela.com

Latest Breaking News On - Peking university people - Page 1 : comparemela.com

Innovent to Present Multiple Clinical Study Results of Mazdutide at the ADA's 84th Scientific Sessions

/PRNewswire/ Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes.

United-states
Suzhou
Jiangsu
China
Peking
Beijing
American
Chinese
Adimab-incyte
Innovent-biologics
Eli-lilly
Linong-ji

EHA 2024 | Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for Presentations at 2024 European Hematology Association Hybrid Congress

SUZHOU, China and ROCKVILLE, Md., May 15, 2024 /PRNewswire/ Ascentage Pharma , a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B , and.

Spain
Australia
Rockville
Pennsylvania
United-states
China
Madrid
Nanfang
Guangdong
Florida
Hong-kong
Peking

EHA 2024 Results From Five Studies Of Ascentage Pharma's Key Drug Candidates Selected For Presentations At 2024 European Hematology Association Hybri...

EHA 2024 Results From Five Studies Of Ascentage Pharma's Key Drug Candidates Selected For Presentations At 2024 European Hematology Association Hybri...
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Hong-kong
Peking
Beijing
China
Philadelphia
Pennsylvania
United-states
Texas
Spain
Suzhou
Jiangsu
Madrid

HUTCHMED Initiates the RAPHAEL Registrational Phase III Trial of HMPL-306 for Patients with IDH1- and/or IDH2-Mutated Relapsed/Refractory Acute Myel

HUTCHMED Initiates the RAPHAEL Registrational Phase III Trial of HMPL-306 for Patients with IDH1- and/or IDH2-Mutated Relapsed/Refractory Acute Myel
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

China
Hong-kong
Peking
Beijing
Xiaojun-huang
University-people-hospital
National-cancer-institute
Linkedin
European-hematology-association-congress
Drug-administration
Nasdaq
China-limited

HUTCHMED Initiates the RAPHAEL Registrational Phase III Trial of HMPL-306 for Patients with IDH1- and/or IDH2-Mutated Relapsed/Refractory Acute Myeloid Leukemia in China

HUTCHMED Initiates the RAPHAEL Registrational Phase III Trial of HMPL-306 for Patients with IDH1- and/or IDH2-Mutated Relapsed/Refractory Acute Myeloid Leukemia in China
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

China
Hong-kong
Peking
Beijing
Shanghai
Chinese
Ben-atwell-alex-shaw
Ann-hematol
Xiaojun-huang
Zhou-yi
Atholl-tweedie
China-limited

vimarsana © 2020. All Rights Reserved.